NewslettersImmunology of Infectious Disease NewsOtilonium Bromide Boosts Antimicrobial Activities of Colistin against Gram-Negative Pathogens and Their PersistersBy Danielle Corrigan - June 21, 20220151Scientists identified an FDA-approved drug, Otilonium bromide, which restored the activity of colistin against colistin-resistant Gram-negative bacteria in vitro and in a mouse infection model.[Communications Biology]Full Article